Marqibo
Total Payments
$383,541
Transactions
297
Doctors
234
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $44,449 | 83 | 69 |
| 2019 | $76,952 | 102 | 97 |
| 2018 | $179,528 | 90 | 67 |
| 2017 | $82,612 | 22 | 15 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $225,000 | 3 | 58.7% |
| Unspecified | $139,262 | 7 | 36.3% |
| Education | $14,250 | 62 | 3.7% |
| Food and Beverage | $4,129 | 222 | 1.1% |
| Travel and Lodging | $699.52 | 2 | 0.2% |
| Consulting Fee | $200.00 | 1 | 0.1% |
Payments by Type
General
$244,279
290 transactions
Research
$139,262
7 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| T2012-002 MARQIBO | Spectrum Pharmaceuticals Inc. | $44,750 | 0 |
| Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) study for Marqibo | Aurobindo Pharma USA, Inc. | $43,250 | 0 |
| 2016-0211 | Spectrum Pharmaceuticals Inc. | $22,737 | 0 |
| BrUOG L326 | Spectrum Pharmaceuticals Inc. | $20,275 | 0 |
| TTX404 Marqibo P3 All HALLMARQ | Spectrum Pharmaceuticals Inc. | $8,250 | 0 |
Top Doctors Receiving Payments for Marqibo — Page 6
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Hematology & Oncology | Tucson, AZ | $17.69 | 1 |
| Syed Abutalib | Medical Oncology | Chicago, IL | $17.58 | 1 |
| Anuj Agarwala | Hematology | Indianapolis, IN | $17.56 | 1 |
| , M.D | Hematology & Oncology | Tucson, AZ | $17.13 | 1 |
| , MD | Internal Medicine | Phoenix, AZ | $17.13 | 1 |
| , D.O | Hematology & Oncology | Tucson, AZ | $17.13 | 1 |
| , M.D | Hematology | Fort Myers, FL | $16.97 | 1 |
| Masood Ghouse | Hematology & Oncology | Greenwood, IN | $16.78 | 1 |
| Nicholas Gustafson | Hospitalist | Milwaukee, WI | $16.77 | 1 |
| , M.D | Medical Oncology | Fort Myers, FL | $16.46 | 1 |
| , M.D | Medical Oncology | Nashville, TN | $16.24 | 1 |
| , M.D | Hematology & Oncology | New Albany, IN | $16.08 | 1 |
| , M.D | Hematology & Oncology | New York, NY | $16.07 | 1 |
| , M.D | Radiation Oncology | Indianapolis, IN | $16.07 | 1 |
| , MD | Hematology & Oncology | Dayton, OH | $16.06 | 1 |
| , MD | Medical Oncology | Dayton, OH | $16.06 | 1 |
| , MD | Hematology & Oncology | Dayton, OH | $16.05 | 1 |
| , M.D | Hematology & Oncology | Tucson, AZ | $15.90 | 1 |
| , MD | Hematology & Oncology | Tucson, AZ | $15.90 | 1 |
| , M.D | Radiation Oncology | Lebanon, TN | $15.85 | 1 |
| , MD | Hematology & Oncology | Fort Myers, FL | $15.61 | 1 |
| , MD | Hematology | Fort Myers, FL | $15.53 | 1 |
| , M.D | Hematology | Fort Myers, FL | $15.39 | 1 |
| , MD | Hematology & Oncology | Indianapolis, IN | $15.39 | 1 |
| , MD | Hematology & Oncology | Indianapolis, IN | $15.39 | 1 |
Ad
Manufacturing Companies
- Spectrum Pharmaceuticals Inc. $337,472
- Aurobindo Pharma USA, Inc. $46,068
Product Information
- Type Drug
- Total Payments $383,541
- Total Doctors 234
- Transactions 297
About Marqibo
Marqibo is a drug associated with $383,541 in payments to 234 healthcare providers, recorded across 297 transactions in the CMS Open Payments database. The primary manufacturer is Spectrum Pharmaceuticals Inc..
Payment data is available from 2017 to 2020. In 2020, $44,449 was paid across 83 transactions to 69 doctors.
The most common payment nature for Marqibo is "Royalty or License" ($225,000, 58.7% of total).
Marqibo is associated with 5 research studies, including "T2012-002 MARQIBO" ($44,750).